RxDoctor Payments Data

Justin McWilliams, MD

Vascular & Interventional Radiology · Los Angeles, CANPI 1437292331

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (48.3%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 26 manufacturers reported payments, led by Terumo Medical Corporation at 29.2% of the total. Among vascular & interventional radiology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$264,665in general payments, 2019–2025

Across 377 payments — averaging $702.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Terumo Medical Corporation$77K
  • Penumbra, Inc.$77K
  • Siemens Medical Solutions USA, Inc.$41K
  • Medical Device Business Services, Inc.$22K
  • Asahi Intecc USA, Inc.$16K
  • Boston Scientific$14K
  • plus $18K from 20 others
$91,856in research payments, 2019–2025

Across 15 payments — averaging $6123.71 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Merit Medical Systems Inc$90K
  • Asahi Intecc USA, Inc.$2K

What the payments were for

  • Consulting fees$127,76148%
  • Speaking & faculty fees$74,22528%
  • Travel & lodging$49,69619%
  • Food & beverage$12,9845%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$264,665 in reported general payments places this provider in the 95th percentile of 504 vascular & interventional radiology providers in California.

See all vascular & interventional radiology providers in California

Medicare billing

Part B allowed, 2024
$151,149
Medicare patients
304
Services billed
1,311

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciprofloxacin Hcl31$113
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen29$97
Naproxen19$53

Paid to pharmacies, not to this prescriber.

Other vascular & interventional radiology in Los Angeles

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →